SCHEMBL29411418

SCHEMBL29411418

Cc1ccc(C(=O)NCC(F)(F)Cc2ccc(-c3ccccc3F)cc2)cn1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA5 P31644 5/20 0.47
ALDH1A1 P00352 1/20 0.44
MAPT P10636 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
KDM4E B2RXH2 1/20 0.42
NPC1 O15118 1/20 0.41
PKM P14618 1/20 0.41
RAB9A P51151 1/20 0.41
HDAC1 Q13547 2/20 0.40
HDAC6 Q9UBN7 2/20 0.40
HIF1A Q16665 1/20 0.39
KMT2A Q03164 1/20 0.39
KLKB1 P03952 1/20 0.39
PPARG P37231 1/20 0.39
BUB1 O43683 1/20 0.38
CYP2C9 P11712 1/20 0.38
PRKACG P22612 1/20 0.38
MAPKAPK2 P49137 1/20 0.38
MAPK11 Q15759 1/20 0.38
MAPK14 Q16539 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21045312 1.00 GABRA5 (0.47) GABRA5ALDH1A1MAPTL3MBTL1KDM4E
SCHEMBL21100332 0.84 SCN9A (0.38) GABRA5ALDH1A1MAPTL3MBTL1KDM4E
SCHEMBL29411410 0.81 KDM4E (0.55) ALDH1A1MAPTL3MBTL1KDM4ENPC1
SCHEMBL21045178 0.81 KDM4E (0.55) ALDH1A1MAPTL3MBTL1KDM4ENPC1
SCHEMBL21045589 0.80 KDM4E (0.47) GABRA5ALDH1A1MAPTL3MBTL1KDM4E
SCHEMBL29411415 0.80 KDM4E (0.47) GABRA5ALDH1A1MAPTL3MBTL1KDM4E
SCHEMBL29411582 0.77 KMT2A (0.53) ALDH1A1MAPTL3MBTL1KDM4ENPC1
SCHEMBL21045353 0.77 KMT2A (0.53) ALDH1A1MAPTL3MBTL1KDM4ENPC1
SCHEMBL21045182 0.76 EPHX2 (0.48) ALDH1A1MAPTL3MBTL1KDM4ENPC1
SCHEMBL29411419 0.76 EPHX2 (0.48) ALDH1A1MAPTL3MBTL1KDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250188035-A1 TUBULIN INHIBITORS LIN BIOSCIENCE LLC (US) 2025-06-12 US disclosed
US-12247010-B2 Tubulin inhibitors LIN BIOSCIENCE INC. (TW) 2025-03-11 US disclosed
US-20220089539-A1 TUBULIN INHIBITORS LIN BIOSCIENCE INC. (TW) 2022-03-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220089539-A1 TUBULIN INHIBITORS TUBB3, TUBB1, TUBB GABRA5 2591/4885ALDH1A1 3048/4885MAPT 24/4885
US-12247010-B2 Tubulin inhibitors TUBB3, TUBB1, TUBB GABRA5 2591/4885ALDH1A1 3048/4885MAPT 24/4885
US-20250188035-A1 TUBULIN INHIBITORS TUBB3, TUBB1, TUBB GABRA5 2591/4885ALDH1A1 3048/4885MAPT 24/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.